Tag Archives: pfizer

India: Varenacline Patent revoked

Varenaciline is marketed by Pfizer world wide as Chandix or Champix. Varenaciline is marketed as tartarate salt form, this salt form is protected by US patent 6890927 and its indian equivalent is 204091 (863/MUMNP/2003). This ‘091 patent is opposed by Dr … Continue reading

Posted in Patent case | Tagged , , , , , | Leave a comment